{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:14:57Z","timestamp":1784805297776,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Precision Medical Research Program of China","award":["2016YFC0905602"],"award-info":[{"award-number":["2016YFC0905602"]}]},{"name":"Beijing Municipal Science and Technology Project","award":["Z181100001718200"],"award-info":[{"award-number":["Z181100001718200"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81370326"],"award-info":[{"award-number":["81370326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81641005"],"award-info":[{"award-number":["81641005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10741-019-09802-4","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T04:49:54Z","timestamp":1557809394000},"page":"1031-1040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Research progress on the pathogenesis of CTEPH"],"prefix":"10.1007","volume":"24","author":[{"given":"Lu","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"24","key":"9802_CR1","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1055\/s-0042-117784","volume":"141","author":"C Opitz","year":"2016","unstructured":"Opitz C, Rosenkranz S, Ghofrani HA, Gr\u00fcnig E, Klose H, Olschewski H, Hoeper M (2016) ESC guidelines 2015 pulmonary hypertension: diagnosis and treatment. Dtsch Med Wochenschr 141(24):1764\u20131769","journal-title":"Dtsch Med Wochenschr"},{"issue":"2","key":"9802_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1183\/09031936.00049312","volume":"41","author":"IM Lang","year":"2013","unstructured":"Lang IM, Pesavento R, Bonderman D, Yuan JX (2013) Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 41(2):462\u2013468","journal-title":"Eur Respir J"},{"issue":"3","key":"9802_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccm.2018.04.018","volume":"39","author":"JM Elwing","year":"2018","unstructured":"Elwing JM, Vaidya A, Auger WR (2018) Chronic thromboembolic pulmonary hypertension: An Update. Clin Chest Med 39(3):605\u2013620","journal-title":"Clin Chest Med"},{"issue":"143","key":"9802_CR4","doi-asserted-by":"publisher","first-page":"160121","DOI":"10.1183\/16000617.0121-2016","volume":"26","author":"H Gall","year":"2017","unstructured":"Gall H, Hoeper MM, Richter MJ, Cacheris W, Hinzmann B, Mayer E (2017) An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur Respir Rev 26(143):160121","journal-title":"Eur Respir Rev"},{"issue":"9","key":"9802_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.amjmed.2016.03.006","volume":"129","author":"VF Tapson","year":"2016","unstructured":"Tapson VF, Platt DM, Xia F, Teal SA, de la Orden M, Divers CH, Satler CA, Joish VN, Channick RN (2016) Monitoring for pulmonary hypertension following pulmonary embolism: the INFORM study. Am J Med 129(9):978\u2013985 e972","journal-title":"Am J Med"},{"issue":"22","key":"9802_CR6","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1056\/NEJMoa032274","volume":"350","author":"V Pengo","year":"2004","unstructured":"Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P, Thromboembolic Pulmonary Hypertension Study Group (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350(22):2257\u20132264","journal-title":"N Engl J Med"},{"issue":"11","key":"9802_CR7","first-page":"1927","volume":"7","author":"S Yang","year":"2015","unstructured":"Yang S, Yang Y, Zhai Z, Kuang T, Gong J, Zhang S, Zhu J, Liang L, Shen YH, Wang C (2015) Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. J Thorac Dis 7(11):1927\u20131938","journal-title":"J Thorac Dis"},{"issue":"3","key":"9802_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1183\/09031936.00101211","volume":"40","author":"P Escribano-Subias","year":"2012","unstructured":"Escribano-Subias P, Blanco I, Lopez-Meseguer M et al (2012) Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J 40(3):596\u2013603","journal-title":"Eur Respir J"},{"key":"9802_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2018.01.012","volume":"164","author":"T Fernandes","year":"2018","unstructured":"Fernandes T, Auger W, Fedullo P (2018) Epidemiology and risk factors for chronic thromboembolic pulmonary hypertension. Thromb Res 164:145\u2013149","journal-title":"Thromb Res"},{"issue":"3","key":"9802_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0167-5273(88)90291-4","volume":"20","author":"K Woo","year":"1988","unstructured":"Woo K, Tse L, Tse C, Metreweli C, Vallance-Owen J (1988) The prevalence and pattern of pulmonary thromboembolism in the Chinese in Hong Kong. Int J Cardiol 20(3):373\u2013380","journal-title":"Int J Cardiol"},{"issue":"11","key":"9802_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026861","volume":"6","author":"Y Yang","year":"2011","unstructured":"Yang Y, Liang L, Zhai Z, He H, Xie W, Peng X, Wang C, on behalf of investigators for the National Cooperative Project for the Prevention and Treatment of PTE-DVT (2011) Pulmonary embolism incidence and fatality trends in Chinese hospitals from 1997 to 2008: a multicenter registration study. PLoS One 6(11):e26861","journal-title":"PLoS One"},{"issue":"18","key":"9802_CR12","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","volume":"124","author":"J Pepke-Zaba","year":"2011","unstructured":"Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barber\u00e0 JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Ja\u00efs X, Simonneau G (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124(18):1973\u20131981","journal-title":"Circulation"},{"issue":"2","key":"9802_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00408-016-9842-y","volume":"194","author":"N Al-Naamani","year":"2016","unstructured":"Al-Naamani N, Espitia HG, Velazquez-Moreno H et al (2016) Chronic thromboembolic pulmonary hypertension: experience from a single center in Mexico. Lung 194(2):315\u2013323","journal-title":"Lung"},{"issue":"2","key":"9802_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1378\/chest.81.2.151","volume":"81","author":"M Riedel","year":"1982","unstructured":"Riedel M, Stanek V, Widimsky J, Prerovsky I (1982) Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 81(2):151\u2013158","journal-title":"Chest"},{"issue":"3","key":"9802_CR15","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1378\/chest.119.3.818","volume":"119","author":"J Lewczuk","year":"2001","unstructured":"Lewczuk J, Piszko P, Jagas J, Porada A, Sobkowicz B, Wrabec K, W\u00f3jciak S (2001) Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 119(3):818\u2013823","journal-title":"Chest"},{"issue":"4","key":"9802_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ccm.2010.07.006","volume":"31","author":"WR Auger","year":"2010","unstructured":"Auger WR, Kim NH, Trow TK (2010) Chronic thromboembolic pulmonary hypertension. Clin Chest Med 31(4):741\u2013758","journal-title":"Clin Chest Med"},{"issue":"3","key":"9802_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1034\/j.1399-3003.2000.15.03.x","volume":"15","author":"P Egermayer","year":"2000","unstructured":"Egermayer P, Peacock AJ (2000) Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J 15(3):440\u2013448","journal-title":"Eur Respir J"},{"issue":"6","key":"9802_CR18","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1161\/01.CIR.87.6.1990","volume":"87","author":"IM Lang","year":"1993","unstructured":"Lang IM, Marsh JJ, Konopka RG, Olman MA, Binder BR, Moser KM, Schleef RR (1993) Factors contributing to increased vascular fibrinolytic activity in mongrel dogs. Circulation 87(6):1990\u20132000","journal-title":"Circulation"},{"issue":"9","key":"9802_CR19","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood.V80.9.2269.2269","volume":"80","author":"IM Lang","year":"1992","unstructured":"Lang IM, Marsh J, Moser K, Schleef R (1992) Presence of active and latent type 1 plasminogen activator inhibitor associated with porcine platelets. Blood 80(9):2269\u20132274","journal-title":"Blood"},{"issue":"20","key":"9802_CR20","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMra010902","volume":"345","author":"PF Fedullo","year":"2001","unstructured":"Fedullo PF, Auger WR, Kerr KM, Rubin LJ (2001) Chronic thromboembolic pulmonary hypertension. N Engl J Med 345(20):1465\u20131472","journal-title":"N Engl J Med"},{"issue":"5","key":"9802_CR21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01980-2016","volume":"49","author":"R Pesavento","year":"2017","unstructured":"Pesavento R, Filippi L, Palla A, Vison\u00e0 A, Bova C, Marzolo M, Porro F, Villalta S, Ciammaichella M, Bucherini E, Nante G, Battistelli S, Muiesan ML, Beltramello G, Prisco D, Casazza F, Ageno W, Palareti G, Quintavalla R, Monti S, Mumoli N, Zanatta N, Cappelli R, Cattaneo M, Moretti V, Cor\u00e0 F, Bazzan M, Ghirarduzzi A, Frigo AC, Miniati M, Prandoni P, SCOPE Investigators (2017) Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. Eur Respir J 49(5):1601980","journal-title":"Eur Respir J"},{"issue":"2","key":"9802_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1253\/circj.CJ-13-1016","volume":"78","author":"S Yamaki","year":"2014","unstructured":"Yamaki S, Ando M, Fukumoto Y, Higuchi Y, Kaneko K, Maeda K, Shimokawa H (2014) Histopathological examination by lung biopsy for the evaluation of operability and postoperative prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 78(2):476\u2013482","journal-title":"Circ J"},{"issue":"6","key":"9802_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.114.009309","volume":"130","author":"IM Lang","year":"2014","unstructured":"Lang IM, Madani M (2014) Update on chronic thromboembolic pulmonary hypertension. Circulation 130(6):508\u2013518","journal-title":"Circulation"},{"issue":"1","key":"9802_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cpcardiol.2016.11.001","volume":"42","author":"JA Edward","year":"2017","unstructured":"Edward JA, Mandras S (2017) An update on the management of chronic thromboembolic pulmonary hypertension. Curr Probl Cardiol 42(1):7\u201338","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"9802_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/01.md.0000236952.87590.c8","volume":"85","author":"M Miniati","year":"2006","unstructured":"Miniati M, Monti S, Bottai M, Scoscia E, Bauleo C, Tonelli L, Dainelli A, Giuntini C (2006) Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore) 85(5):253\u2013262","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"9802_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1378\/chest.130.1.172","volume":"130","author":"C Becattini","year":"2006","unstructured":"Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, Ageno W (2006) Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 130(1):172\u2013175","journal-title":"Chest"},{"issue":"6","key":"9802_CR27","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3324\/haematol.2009.018960","volume":"95","author":"FA Klok","year":"2010","unstructured":"Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV (2010) Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica 95(6):970\u2013975","journal-title":"Haematologica"},{"issue":"3","key":"9802_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11239-010-0452-x","volume":"30","author":"D Poli","year":"2010","unstructured":"Poli D, Grifoni E, Antonucci E, Arcangeli C, Prisco D, Abbate R, Miniati M (2010) Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism. J Thromb Thrombolysis 30(3):294\u2013299","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"9802_CR29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1160\/TH13-07-0538","volume":"112","author":"L Guerin","year":"2014","unstructured":"Guerin L, Couturaud F, Parent F et al (2014) Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost 112(3):598\u2013605","journal-title":"Thromb Haemost"},{"issue":"4","key":"9802_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.thromres.2010.12.010","volume":"127","author":"R Otero","year":"2011","unstructured":"Otero R, Oribe M, Ballaz A, Jimenez D, Uresandi F, Nauffal D, Conget F, Rodriguez C, Elias T, Jara L, Cayuela A, Blanco I, Barber\u00e1 J (2011) Echocardiographic assessment of pulmonary arterial pressure in the follow-up of patients with pulmonary embolism. Thromb Res 127(4):303\u2013308","journal-title":"Thromb Res"},{"issue":"3","key":"9802_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.thromres.2009.01.003","volume":"124","author":"F Dentali","year":"2009","unstructured":"Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, Venco A, Ageno W (2009) Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res 124(3):256\u2013258","journal-title":"Thromb Res"},{"issue":"3","key":"9802_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/1076029611431956","volume":"18","author":"A Korkmaz","year":"2012","unstructured":"Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y (2012) Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost 18(3):281\u2013288","journal-title":"Clin Appl Thromb Hemost"},{"issue":"12","key":"9802_CR33","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1164\/rccm.201011-1854CI","volume":"183","author":"P Fedullo","year":"2011","unstructured":"Fedullo P, Kerr KM, Kim NH, Auger WR (2011) Chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 183(12):1605\u20131613","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"9802_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1183\/09031936.00087608","volume":"33","author":"D Bonderman","year":"2009","unstructured":"Bonderman D, Wilkens H, Wakounig S, Sch\u00e4fers HJ, Jansa P, Lindner J, Simkova I, Martischnig AM, Dudczak J, Sadushi R, Skoro-Sajer N, Klepetko W, Lang IM (2009) Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 33(2):325\u2013331","journal-title":"Eur Respir J"},{"issue":"3","key":"9802_CR35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1160\/TH04-10-0657","volume":"93","author":"D Bonderman","year":"2005","unstructured":"Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle P, Sch\u00f6nauer V, Exner M, Klepetko W, Kneussl M, Maurer G, Lang I (2005) Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 93(3):512\u2013516","journal-title":"Thromb Haemost"},{"issue":"123","key":"9802_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1183\/09059180.00009111","volume":"21","author":"NH Kim","year":"2012","unstructured":"Kim NH, Lang IM (2012) Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir Rev 21(123):27\u201331","journal-title":"Eur Respir Rev"},{"issue":"7","key":"9802_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/NEJM200008173430702","volume":"343","author":"PA Kyrle","year":"2000","unstructured":"Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 343(7):457\u2013462","journal-title":"N Engl J Med"},{"issue":"3","key":"9802_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1160\/TH03-02-0067","volume":"90","author":"D Bonderman","year":"2003","unstructured":"Bonderman D, Turecek PL, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B, Kneussl M, Rubin L, Kyrle P, Klepetko W, Maurer G, Lang I (2003) High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 90(3):372\u2013376","journal-title":"Thromb Haemost"},{"issue":"3","key":"9802_CR39","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","volume":"105","author":"T Lisman","year":"2005","unstructured":"Lisman T, de Groot PG, Meijers JC, Rosendaal FR (2005) Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 105(3):1102\u20131105","journal-title":"Blood"},{"issue":"5","key":"9802_CR40","first-page":"422","volume":"19","author":"TA Morris","year":"2013","unstructured":"Morris TA (2013) Why acute pulmonary embolism becomes chronic thromboembolic pulmonary hypertension: clinical and genetic insights. Curr Opin Pulm Med 19(5):422\u2013429","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"9802_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jcp.22783","volume":"227","author":"AK Ghosh","year":"2012","unstructured":"Ghosh AK, Vaughan DE (2012) PAI-1 in tissue fibrosis. J Cell Physiol 227(2):493\u2013507","journal-title":"J Cell Physiol"},{"issue":"9800","key":"9802_CR42","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(11)61144-6","volume":"378","author":"A Vuylsteke","year":"2011","unstructured":"Vuylsteke A, Sharples L, Charman G, Kneeshaw J, Tsui S, Dunning J, Wheaton E, Klein A, Arrowsmith J, Hall R, Jenkins D (2011) Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet 378(9800):1379\u20131387","journal-title":"Lancet"},{"issue":"2","key":"9802_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/01.CIR.90.2.706","volume":"90","author":"IM Lang","year":"1994","unstructured":"Lang IM, Marsh JJ, Olman MA, Moser KM, Schleef RR (1994) Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli. Circulation 90(2):706\u2013712","journal-title":"Circulation"},{"issue":"11","key":"9802_CR44","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1164\/rccm.200506-916OC","volume":"173","author":"TA Morris","year":"2006","unstructured":"Morris TA, Marsh JJ, Chiles PG, Auger WR, Fedullo PF, Woods VL Jr (2006) Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med 173(11):1270\u20131275","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"9802_CR45","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1182\/blood-2009-03-208264","volume":"114","author":"TA Morris","year":"2009","unstructured":"Morris TA, Marsh JJ, Chiles PG, Magana MM, Liang NC, Soler X, DeSantis DJ, Ngo D, Woods VL (2009) High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 114(9):1929\u20131936","journal-title":"Blood"},{"issue":"9","key":"9802_CR46","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1164\/rccm.200907-1135OC","volume":"181","author":"M Miniati","year":"2010","unstructured":"Miniati M, Fiorillo C, Becatti M, Monti S, Bottai M, Marini C, Grifoni E, Formichi B, Bauleo C, Arcangeli C, Poli D, Nassi PA, Abbate R, Prisco D (2010) Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. Am J Respir Crit Care Med 181(9):992\u2013996","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"9802_CR47","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1183\/09031936.00055107","volume":"31","author":"J Suntharalingam","year":"2008","unstructured":"Suntharalingam J, Goldsmith K, van Marion V, Long L, Treacy CM, Dudbridge F, Toshner MR, Pepke-Zaba J, Eikenboom JCJ, Morrell NW (2008) Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 31(4):736\u2013741","journal-title":"Eur Respir J"},{"issue":"18","key":"9802_CR48","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1161\/01.CIR.0000066690.89407.CE","volume":"107","author":"KF Standeven","year":"2003","unstructured":"Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariens RA (2003) Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation 107(18):2326\u20132330","journal-title":"Circulation"},{"issue":"19","key":"9802_CR49","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1182\/blood-2013-04-499558","volume":"122","author":"J Kellermair","year":"2013","unstructured":"Kellermair J, Redwan B, Alias S, Jabkowski J, Panzenboeck A, Kellermair L, Winter MP, Weltermann A, Lang IM (2013) Platelet endothelial cell adhesion molecule 1 deficiency misguides venous thrombus resolution. Blood 122(19):3376\u20133384","journal-title":"Blood"},{"issue":"4","key":"9802_CR50","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/ATVBAHA.107.156000","volume":"28","author":"D Bonderman","year":"2008","unstructured":"Bonderman D, Jakowitsch J, Redwan B, Bergmeister H, Renner MK, Panzenb\u00f6ck H, Adlbrecht C, Georgopoulos A, Klepetko W, Kneussl M, Lang IM (2008) Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 28(4):678\u2013684","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"9802_CR51","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1183\/09031936.00145013","volume":"44","author":"D Zabini","year":"2014","unstructured":"Zabini D, Heinemann A, Foris V, Nagaraj C, Nierlich P, B\u00e1lint Z, Kwapiszewska G, Lang IM, Klepetko W, Olschewski H, Olschewski A (2014) Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients. Eur Respir J 44(4):951\u2013962","journal-title":"Eur Respir J"},{"issue":"14","key":"9802_CR52","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.jacc.2008.12.038","volume":"53","author":"R Quarck","year":"2009","unstructured":"Quarck R, Nawrot T, Meyns B, Delcroix M (2009) C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 53(14):1211\u20131218","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"9802_CR53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1055\/s-2007-985753","volume":"33","author":"DM Cohn","year":"2007","unstructured":"Cohn DM, Roshani S, Middeldorp S (2007) Thrombophilia and venous thromboembolism: implications for testing. Semin Thromb Hemost 33(6):573\u2013581","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"9802_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1034\/j.1399-3003.2000.15b28.x","volume":"15","author":"M Wolf","year":"2000","unstructured":"Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, Simonneau G (2000) Thrombotic risk factors in pulmonary hypertension. Eur Respir J 15(2):395\u2013399","journal-title":"Eur Respir J"},{"issue":"3","key":"9802_CR55","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/MBC.0b013e328331e664","volume":"21","author":"CL Wong","year":"2010","unstructured":"Wong CL, Szydlo R, Gibbs S, Laffan M (2010) Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis 21(3):201\u2013206","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7","key":"9802_CR56","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/jth.12291","volume":"11","author":"LA Lotta","year":"2013","unstructured":"Lotta LA, Tuana G, Yu J, Martinelli I, Wang M, Yu F, Passamonti SM, Pappalardo E, Valsecchi C, Scherer SE, Hale W IV, Muzny DM, Randi G, Rosendaal FR, Gibbs RA, Peyvandi F (2013) Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis. J Thromb Haemost 11(7):1228\u20131239","journal-title":"J Thromb Haemost"},{"issue":"1","key":"9802_CR57","first-page":"89","volume":"37","author":"KH Orstavik","year":"1985","unstructured":"Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W (1985) Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 37(1):89\u2013101","journal-title":"Am J Hum Genet"},{"issue":"15","key":"9802_CR58","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/bloodadvances.2017005629","volume":"1","author":"Q Ma","year":"2017","unstructured":"Ma Q, Jacobi PM, Emmer BT, Kretz CA, Ozel AB, McGee B, Kimchi-Sarfaty C, Ginsburg D, Li JZ, Desch KC (2017) Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels. Blood Adv 1(15):1037\u20131046","journal-title":"Blood Adv"},{"issue":"5","key":"9802_CR59","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1182\/blood-2006-07-038166","volume":"109","author":"CK Chion","year":"2007","unstructured":"Chion CK, Doggen CJ, Crawley JT, Lane DA, Rosendaal FR (2007) ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. Blood 109(5):1998\u20132000","journal-title":"Blood"},{"issue":"3","key":"9802_CR60","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01805-2018","volume":"53","author":"M Newnham","year":"2019","unstructured":"Newnham M, South K, Bleda M, Auger WR, Barber\u00e0 JA, Bogaard H, Bunclark K, Cannon JE, Delcroix M, Hadinnapola C, Howard LS, Jenkins D, Mayer E, Ng C, Rhodes CJ, Screaton N, Sheares K, Simpson MA, Southwood M, Su L, Taboada D, Traylor M, Trembath RC, Villar SS, Wilkins MR, Wharton J, Gr\u00e4f S, Pepke-Zaba J, Laffan M, Lane DA, Morrell NW, Toshner M (2019) The ADAMTS13\u2013VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension. Eur Respir J 53(3):1801805","journal-title":"Eur Respir J"},{"issue":"4","key":"9802_CR61","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00408-014-9580-y","volume":"192","author":"YX Feng","year":"2014","unstructured":"Feng YX, Liu D, Sun ML, Jiang X, Sun N, Mao YM, Jing ZC (2014) BMPR2 germline mutation in chronic thromboembolic pulmonary hypertension. Lung 192(4):625\u2013627","journal-title":"Lung"},{"issue":"4","key":"9802_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000250322","volume":"79","author":"S Ulrich","year":"2010","unstructured":"Ulrich S, Szamalek-Hoegel J, Hersberger M, Fischler M, Garcia JS, Huber LC, Gr\u00fcnig E, Janssen B, Speich R (2010) Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease. Respiration 79(4):279\u2013287","journal-title":"Respiration"},{"issue":"3","key":"9802_CR63","first-page":"149","volume":"47","author":"JH Distler","year":"2003","unstructured":"Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O (2003) Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 47(3):149\u2013161","journal-title":"Q J Nucl Med"},{"issue":"5","key":"9802_CR64","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1067\/mva.2000.110882","volume":"32","author":"M Waltham","year":"2000","unstructured":"Waltham M, Burnand KG, Collins M, Smith A (2000) Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi. J Vasc Surg 32(5):988\u2013996","journal-title":"J Vasc Surg"},{"issue":"1","key":"9802_CR65","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1006\/jsre.2001.6122","volume":"99","author":"PK Henke","year":"2001","unstructured":"Henke PK, Wakefield TW, Kadell AM, Linn MJ, Varma MR, Sarkar M, Hawley A, Fowlkes JB, Strieter RM (2001) Interleukin-8 administration enhances venous thrombosis resolution in a rat model. J Surg Res 99(1):84\u201391","journal-title":"J Surg Res"},{"issue":"11","key":"9802_CR66","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/ATVBAHA.114.304404","volume":"34","author":"N Yaoita","year":"2014","unstructured":"Yaoita N, Shirakawa R, Fukumoto Y, Sugimura K, Miyata S, Miura Y, Nochioka K, Miura M, Tatebe S, Aoki T, Yamamoto S, Satoh K, Kimura T, Shimokawa H, Horiuchi H (2014) Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 34(11):2486\u20132494","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"9802_CR67","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1378\/chest.103.3.685","volume":"103","author":"KM Moser","year":"1993","unstructured":"Moser KM, Bloor CM (1993) Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 103(3):685\u2013692","journal-title":"Chest"},{"issue":"6","key":"9802_CR68","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1161\/01.CIR.89.6.2715","volume":"89","author":"IM Lang","year":"1994","unstructured":"Lang IM, Marsh JJ, Olman MA, Moser KM, Loskutoff DJ, Schleef RR (1994) Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli. Circulation 89(6):2715\u20132721","journal-title":"Circulation"},{"issue":"2","key":"9802_CR69","first-page":"185","volume":"28","author":"S Sakao","year":"2013","unstructured":"Sakao S, Tatsumi K (2013) Crosstalk between endothelial cell and thrombus in chronic thromboembolic pulmonary hypertension: perspective. Histol Histopathol 28(2):185\u2013193","journal-title":"Histol Histopathol"},{"key":"9802_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1465-9921-12-109","volume":"12","author":"S Sakao","year":"2011","unstructured":"Sakao S, Hao H, Tanabe N, Kasahara Y, Kurosu K, Tatsumi K (2011) Endothelial-like cells in chronic thromboembolic pulmonary hypertension: crosstalk with myofibroblast-like cells. Respir Res 12:109","journal-title":"Respir Res"},{"issue":"5","key":"9802_CR71","doi-asserted-by":"publisher","first-page":"C1217","DOI":"10.1152\/ajpcell.00416.2009","volume":"298","author":"AL Firth","year":"2010","unstructured":"Firth AL, Yao W, Ogawa A, Madani MM, Lin GY, Yuan JX (2010) Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Cell Physiol 298(5):C1217\u2013C1225","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"9802_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043793","volume":"7","author":"D Zabini","year":"2012","unstructured":"Zabini D, Nagaraj C, Stacher E, Lang IM, Nierlich P, Klepetko W, Heinemann A, Olschewski H, B\u00e1lint Z, Olschewski A (2012) Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction. PLoS One 7(8):e43793","journal-title":"PLoS One"},{"issue":"6","key":"9802_CR73","doi-asserted-by":"publisher","first-page":"L979","DOI":"10.1152\/ajplung.90412.2008","volume":"296","author":"AL Firth","year":"2009","unstructured":"Firth AL, Yau J, White A, Chiles PG, Marsh JJ, Morris TA, Yuan JXJ (2009) Chronic exposure to fibrin and fibrinogen differentially regulates intracellular Ca2+ in human pulmonary arterial smooth muscle and endothelial cells. Am J Physiol Lung Cell Mol Physiol 296(6):L979\u2013L986","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"9802_CR74","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1164\/rccm.201408-1528OC","volume":"192","author":"CJ Rhodes","year":"2015","unstructured":"Rhodes CJ, Im H, Cao A, Hennigs JK, Wang L, Sa S, Chen PI, Nickel NP, Miyagawa K, Hopper RK, Tojais NF, Li CG, Gu M, Spiekerkoetter E, Xian Z, Chen R, Zhao M, Kaschwich M, del Rosario PA, Bernstein D, Zamanian RT, Wu JC, Snyder MP, Rabinovitch M (2015) RNA sequencing analysis detection of a novel pathway of endothelial dysfunction in pulmonary arterial hypertension. Am J Respir Crit Care Med 192(3):356\u2013366","journal-title":"Am J Respir Crit Care Med"},{"issue":"20","key":"9802_CR75","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1161\/CIRCULATIONAHA.110.972745","volume":"122","author":"VB Abdul-Salam","year":"2010","unstructured":"Abdul-Salam VB, Wharton J, Cupitt J, Berryman M, Edwards RJ, Wilkins MR (2010) Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension. Circulation 122(20):2058\u20132067","journal-title":"Circulation"},{"issue":"4","key":"9802_CR76","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCULATIONAHA.114.013317","volume":"131","author":"AR Hemnes","year":"2015","unstructured":"Hemnes AR, Trammell AW, Archer SL, Rich S, Yu C, Nian H, Penner N, Funke M, Wheeler L, Robbins IM, Austin ED, Newman JH, West J (2015) Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension. Circulation. 131(4):401\u2013409 discussion 409","journal-title":"Circulation."}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09802-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09802-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09802-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T23:33:49Z","timestamp":1589326429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09802-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["9802"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09802-4","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"14 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}